News
Mylan has announced the launch of Doxycycline Hyclate Delayed-Release (DR) Tablets USP (200mg), the generic version of Mayne's Doryx. Mylan has announced the launch of 200mg Doxycycline Hyclate ...
Mylan announced the launch of Doxycycline Hyclate Delayed-Release Tablets 50mg, the generic version of Mayne's Doryx. Mylan announced the launch of Doxycycline Hyclate Delayed-Release Tablets 50mg, ...
PITTSBURGH, Feb. 9, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results